Health Catalyst, Inc. (HCAT) Financials

$5.23

south_east
-$0.16 (-2.97%)
Day's range
$5.2
Day's range
$5.49
$300M$300M$200M$200M$100M$100M$0$0-$100M-$100M-$200M-$200MEarning20172017201820182019201920202020202120212022202220232023-20%-20%-30%-30%-40%-40%-50%-50%-60%-60%-70%-70%Profit Margin
Profit Margin
Revenue
Earnings

HCAT Income statement / Annual

Last year (2023), Health Catalyst, Inc.'s total revenue was $295.94 M, an increase of 7.13% from the previous year. In 2023, Health Catalyst, Inc.'s net income was -$118.15 M. See Health Catalyst, Inc.,s key income statements, including revenue, expenses, profit, and income.

Period FY-2023 FY-2022 FY-2021 FY-2020 FY-2019 FY-2018 FY-2017
Period Ended 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017
Operating Revenue $295.94 M $276.24 M $241.93 M $188.85 M $154.94 M $112.57 M $73.08 M
Cost of Revenue $164.11 M $143.05 M $124.35 M $98.08 M $75.35 M $59.85 M $43.64 M
Gross Profit $131.83 M $133.19 M $117.57 M $90.77 M $79.60 M $52.72 M $29.44 M
Gross Profit Ratio 0.45 0.48 0.49 0.48 0.51 0.47 0.4
Research and Development Expenses $72.63 M $75.68 M $62.73 M $53.52 M $46.25 M $38.59 M $28.47 M
General & Administrative Expenses $76.56 M $61.70 M $85.93 M $59.24 M $31.71 M $22.69 M $14.70 M
Selling & Marketing Expenses $67.32 M $87.51 M $75.03 M $55.41 M $47.28 M $44.12 M $25.92 M
Selling, General & Administrative Expenses $143.88 M $149.22 M $160.96 M $114.65 M $79.00 M $66.81 M $40.62 M
Other Expenses $42.22 M $48.30 M $37.53 M $18.73 M $9.21 M -$39,000.00 -$4,000.00
Operating Expenses $261.72 M $273.19 M $261.22 M $186.89 M $134.46 M $112.82 M $74.98 M
Cost And Expenses $422.84 M $416.24 M $385.58 M $284.97 M $209.81 M $172.67 M $118.62 M
Interest Income $16.39 M $5.69 M $831,000.00 $2.09 M $2.81 M $602,000.00 $542,000.00
Interest Expense $7.29 M $1.68 M $16.46 M $11.57 M $3.42 M $2.59 M $1.47 M
Depreciation & Amortization $42.22 M $51.53 M $41.11 M $23.03 M $9.21 M $7.41 M $5.89 M
EBITDA -$68.28 M -$82.92 M -$101.68 M -$79.47 M -$44.48 M -$52.12 M -$39.75 M
EBITDA Ratio -0.23 -0.33 -0.44 -0.41 -0.29 -0.46 -0.54
Operating Income Ratio -0.43 -0.51 -0.59 -0.51 -0.35 -0.53 -0.62
Total Other Income/Expenses Net $9.11 M -$1.68 M -$16.46 M -$20.09 M -$5.09 M -$2.02 M -$1.47 M
Income Before Tax -$117.79 M -$141.68 M -$160.11 M -$116.21 M -$59.95 M -$62.12 M -$47.01 M
Income Before Tax Ratio -0.4 -0.51 -0.66 -0.62 -0.39 -0.55 -0.64
Income Tax Expense $356,000.00 -$4.28 M -$6.90 M -$1.19 M $142,000.00 -$135,000.00 $26,000.00
Net Income -$118.15 M -$137.40 M -$153.21 M -$115.02 M -$60.10 M -$61.98 M -$47.04 M
Net Income Ratio -0.4 -0.5 -0.63 -0.61 -0.39 -0.55 -0.64
EPS -2.09 -2.56 -3.23 -2.91 -3.21 -2.23 -1.69
EPS Diluted -2.09 -2.54 -3.23 -2.91 -3.21 -2.23 -1.69
Weighted Average Shares Out $56.42 M $53.72 M $47.49 M $39.54 M $18.74 M $27.77 M $27.77 M
Weighted Average Shares Out Diluted $56.42 M $54.08 M $47.49 M $39.54 M $18.74 M $27.77 M $27.77 M
Link